About us
Who we are
Our people
Annual Report and Accounts April-December 2019
Our facilities
Governance and structure
Working with us
Academics and researchers
MRC researchers
Helping charities
Partnerships
Pipeline
Licensing opportunities
Funding
Philanthropic Fund
Seed Fund
COVID-19 call
Development Gap Fund
LifeArc-CSO Fund
LifeArc-MRC Innovation Hub
Submit your idea
Capabilities
Drug discovery
Antibody engineering
IP management and protection
Diagnostics development
Careers
Jobs
Industrial placements
Fellowships
News
Latest news
Case studies
Media contacts
COVID-19 Information
Contact us
Pipeline
Small molecule and therapeutic antibodies available
Home
Working with us
Pipeline
PROJECT STAGE
Lead optimisation
Hit to lead
Screening
Assay Development
Key
Small molecule
Biotherapeutics
Antibody drug conjugate
MIF
Inflammation
Matriptase
Inflammation
TAPAS
Alzheimer’s Disease
GalR2
Neuropathic Pain
Netrin-1
Cardiovascular disease; osteolytic diseases /oncology
Where Next?
Drug discovery
Licensing opportunities
Collaborations
My Interest
Academic Scientist
Pharma/Biotech
Medical Charity
MRC Scientist
Research Organisation